Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pyoderma”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Very early researchStudy completedNCT04895566
What this trial is testing

Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma

Who this might be right for
PyodermaPyoderma GangrenosumPyoderma Vegetans+1 more
SWISS BIOPHARMA MED GmbH 10
Large-scale testing (Phase 3)Study completedNCT03311464
What this trial is testing

A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan

Who this might be right for
Pyoderma Gangrenosum
AbbVie 22
Testing effectiveness (Phase 2)Study completedNCT01302795
What this trial is testing

Canakinumab for Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
University of Zurich 5
Testing effectiveness (Phase 2)WithdrawnNCT04274166
What this trial is testing

Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Not applicableWithdrawnNCT05984654
What this trial is testing

Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Ohio State University
Testing effectiveness (Phase 2)UnknownNCT05890703
What this trial is testing

Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream

Who this might be right for
Ulcus CrurisEcthymaUlcer, Leg+1 more
Juerg Hafner 40
Testing effectiveness (Phase 2)Study completedNCT01965613
What this trial is testing

A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Janssen Research & Development, LLC 10
Not applicableLooking for participantsNCT02280733
What this trial is testing

A Real-World Registry of Chronic Wounds and Ulcers

Who this might be right for
Diabetic FootPressure UlcerSurgical Wound Dehiscence+17 more
U.S. Wound Registry 300,000
Post-approval studies (Phase 4)Ended earlyNCT05120726
What this trial is testing

A Novel Therapeutic Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Louisiana State University Health Sciences Center in New Orleans 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444684
What this trial is testing

Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Large-scale testing (Phase 3)Ended earlyNCT02318914
What this trial is testing

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 15
Not applicableStudy completedNCT00436891
What this trial is testing

Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji

Who this might be right for
Streptococcus Group A
National Institute of Allergy and Infectious Diseases (NIAID) 550
Large-scale testing (Phase 3)Ended earlyNCT05343754
What this trial is testing

Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Erasmus Medical Center 3
Testing effectiveness (Phase 2)Ended earlyNCT03072953
What this trial is testing

Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Arena Pharmaceuticals 2
Not applicableStudy completedNCT00884728
What this trial is testing

Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory

Who this might be right for
ScabiesImpetigoPyoderma+1 more
Menzies School of Health Research 2,329
Very early researchWithdrawnNCT05821374
What this trial is testing

Deucravacitinib in PG

Who this might be right for
Pyoderma Gangrenosum
Dartmouth-Hitchcock Medical Center
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Not applicableUnknownNCT04792957
What this trial is testing

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Who this might be right for
Pyoderma GangrenosumHidradenitis SuppurativaPsoriasis
Dokuz Eylul University 120
Testing effectiveness (Phase 2)WithdrawnNCT00690846
What this trial is testing

Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Load More Results